Skip to main content
Figure 5 | Journal of Translational Medicine

Figure 5

From: Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice

Figure 5

Phenotypes of s.c. implanted PC14PE6-RFP tumors and number of CD31-positive blood vessels. (A) Photographic images of subcutaneously implanted PC14PE6-RFP tumors were taken 7 days post PBS-, GLV-1h68-, CPA- or combination treatment begin. (B) Vascular density was measured in CD31-labelled cross-sections of GLV-1h68-, CPA- or combination treated tumors 7 days after treatment start. Shown are the mean values +/- s.d.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us